Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Make a Passover gift and support Jewish journalism. DONATE NOW
News

Bialystoker Home, 90-Year-Old Jewish Institution, Is Declared N.Y. Landmark

A shuttered 90-year-old Jewish nursing home on Manhattan’s Lower East Side has been declared a New York City landmark, a designation that will protect it from being razed.

The New York City Landmarks Preservation Commission decided on May 22 to grant landmark status to the Bialystoker nursing home, which catered to generations of Polish Jews before closing in 2011 under a cloud of controversy.

“This is a special building that retains a strong presence to this day, and tells so many stories of the Jewish community in New York City,” said Landmarks Preservation Commission Chairman Robert B. Tierney in a press statement after the May 22 vote.

The Bialystoker, built in 1923, was shut down in 2011 amid controversy, after the not-for-profit that owned the home sold an adjacent property to a company owned by the president of its board.

The future of the Bialystoker home itself, a striking Art Deco monolith on East Broadway, has been a matter of deep local dispute over the past two years. Developers eyed the lot for condos, with some apparently hoping to knock down the nursing home and replace it with new construction.

Those plans were stymied by the landmarks decision, which means the building cannot be torn down.

The Bialystoker’s board, which owns the building and formerly operated the nursing home, is swamped with debt, and has expressed concern about its ability to afford back pay and benefits it owes former employees.

The board had said that it did not oppose the landmark designation, but has suggested that the designation could make it harder for the group to pay those debts.

One developer that had expressed interested in the building dropped its offer as the landmark process moved forward.

This is a moment of great uncertainty. Here’s what you can do about it.

We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news this Passover. All donations are being matched by the Forward Board - up to $100,000.

This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.

With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give this Passover is invested in the future of the Forward — and telling the American Jewish story fully and fairly.

The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.

Support our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines.
You must comply with the following:

  • Credit the Forward
  • Retain our pixel
  • Preserve our canonical link in Google search
  • Add a noindex tag in Google search

See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.